Blog Article

FDA 21 CFR Part 11 playbook: a buyer's evaluation checklist for eQMS RFPs

A vendor-evaluation checklist — what to ask, what evidence to demand, and what answers fail Part 11 in an inspection.

Use this checklist during eQMS shortlisting. Each control area has the exact question to ask, the artifact to request, and the failure mode that should knock a vendor off the list.

FDA 21 CFR Part 11 playbook — electronic records, e-signatures, audit trail controls

How to use this checklist

This is a Part 11 RFP scorecard, not a regulatory primer. Each section has the question to put into your RFP, the artifact to demand from the vendor, and the failure mode that should disqualify a response. Score each control area pass/fail against the artifact, not the marketing answer.

Buyer questions every vendor must answer

Most teams are not looking for abstract compliance claims. They want to know whether the system produces controlled records, maintains a readable history, limits access appropriately, and ties sign-off events to specific actions.

  • Can the system show who approved what and when? (Artifact: signed audit trail export)
  • Can we retrieve record history quickly during inspection? (Artifact: timed retrieval demo)
  • How are signatures and user roles handled in daily workflows? (Artifact: e-signature SOP + screenshot)
  • Does the vendor ship a Part 11 traceability matrix? (Artifact: TM mapping §11.10/§11.50/§11.300)
  • What happens to the audit trail when a tenant is offboarded? (Artifact: retention + export procedure)

How Complere supports Part 11 compliance

Complere connects Part 11 requirements to daily quality operations: role-based access controls limit who can create, review, and approve records. Workflow sign-off points capture electronic signatures with re-authentication and intent. Time-stamped audit trails record every action, change, and access event across documents, CAPA, audits, training, and change control.

Key control areas

Electronic records, electronic signatures, audit trails, access controls, and system validation — Complere addresses all five core Part 11 control areas in a single governed platform.

Continue Exploring

Explore related topics, modules, and compliance resources for a deeper understanding of your quality system.

Electronic records workflow
Related

Electronic Records & Signatures

Explore this topic in more depth to build a complete picture of your quality and compliance operations.

Explore
Data integrity
Related

Data Integrity & Audit Trails

Explore this topic in more depth to build a complete picture of your quality and compliance operations.

Explore
Audit Readiness
Related

Audit Readiness

Explore this topic in more depth to build a complete picture of your quality and compliance operations.

Explore

Related from the blog

More from the Complere editorial team on quality, validation, and inspection readiness.

Regulatory & Inspection

QMSR vs ISO 13485: What Actually Changes for Quality Systems

See what actually changes when QMSR and ISO 13485 meet in the same quality system, and how medtech teams can keep evidence usable under inspection.

Read the article
Regulatory & Inspection

21 CFR Part 11: What Pharma Teams Actually Need to Know

A practical guide to 21 CFR Part 11 for pharma teams, covering electronic records, signatures, audit trails, validation, and what inspectors expect.

Read the article
Inspection Readiness

Warning Letter Trends 2025: What Recurring Quality-System Breakdowns Reveal

Warning letter analysis 2025: review recurring data integrity, CAPA, training, and validation breakdowns from FDA warning letters and inspection observations.

Read the article

See Part 11 controls in action during a focused demo

Our demo covers the exact electronic record, signature, audit trail, and access controls relevant to your team's Part 11 evaluation.